How big can LTR Pharma get? Who would like to take a guess?
With 20% market share from big pharma by 2026 (far superior product), that is USD900m in EBITDA.
10x 900m = USD 9b or AUD 13.5b. At the 20c IPO price the market cap is only AUD28m.
I hear the FFA submission uses 95% approved clinical data.
Given this, what should it be worth today, 200m, 300m?The potential pay off is nuts.
Ann: Investor Webinar, page-8
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
88.0¢ |
Change
0.100(12.8%) |
Mkt cap ! $61.95M | |||
| Open | High | Low | Value | Volume |
| 78.5¢ | 97.5¢ | 78.0¢ | $643.5K | 743.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 87.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 88.5¢ | 8422 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| LTP (ASX) Chart |